{"id":"https://openalex.org/W2123676752","doi":"https://doi.org/10.1681/asn.2011060610","title":"Circulating Anti-PLA2R Autoantibodies to Monitor Immunological Activity in Membranous Nephropathy","display_name":"Circulating Anti-PLA2R Autoantibodies to Monitor Immunological Activity in Membranous Nephropathy","publication_year":2011,"publication_date":"2011-07-23","ids":{"openalex":"https://openalex.org/W2123676752","doi":"https://doi.org/10.1681/asn.2011060610","mag":"2123676752","pmid":"https://pubmed.ncbi.nlm.nih.gov/21784892"},"language":"en","primary_location":{"id":"doi:10.1681/asn.2011060610","doi":"https://doi.org/10.1681/asn.2011060610","is_oa":true,"landing_page_url":"https://doi.org/10.1681/asn.2011060610","pdf_url":"https://jasn.asnjournals.org/content/jnephrol/22/8/1400.full.pdf","source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jasn.asnjournals.org/content/jnephrol/22/8/1400.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005075162","display_name":"Paolo Cravedi","orcid":"https://orcid.org/0000-0001-7837-0923","observed_orcids":["https://orcid.org/0000-0001-7837-0923"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo Cravedi","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso and Unit of Nephrology and Dialysis, Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso and Unit of Nephrology and Dialysis, Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059276594","display_name":"Piero Luigi Ruggenenti","orcid":"https://orcid.org/0000-0002-8394-0879","observed_orcids":["https://orcid.org/0000-0002-8394-0879"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Piero Ruggenenti","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso and Unit of Nephrology and Dialysis, Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso and Unit of Nephrology and Dialysis, Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023556434","display_name":"Giuseppe Remuzzi","orcid":"https://orcid.org/0000-0002-6194-3446","observed_orcids":["https://orcid.org/0000-0002-6194-3446"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giuseppe Remuzzi","raw_affiliation_strings":["Dr. Giuseppe Remuzzi, Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Via Stezzano, 87, 24126 Bergamo, Italy. Phone: +39-035-42131; Fax: +39-035-319-331; E-mail: [email\u00a0protected]","Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso and Unit of Nephrology and Dialysis, Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy","Dr. Giuseppe Remuzzi, Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Via Stezzano, 87, 24126 Bergamo, Italy. Phone: +39-035-42131","E-mail: [email\u00a0protected]","Fax: +39-035-319-331"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Giuseppe Remuzzi, Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Via Stezzano, 87, 24126 Bergamo, Italy. Phone: +39-035-42131; Fax: +39-035-319-331; E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso and Unit of Nephrology and Dialysis, Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Dr. Giuseppe Remuzzi, Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Via Stezzano, 87, 24126 Bergamo, Italy. Phone: +39-035-42131","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"E-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"Fax: +39-035-319-331","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023556434"],"corresponding_institution_ids":["https://openalex.org/I19630809"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":28,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"8","first_page":"1400","last_page":"1402"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-membranous-nephropathy","display_name":"idiopathic membranous nephropathy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/anti-pla2r-autoantibodies","display_name":"anti-PLA2R autoantibodies","score":0.9279999732971191},{"id":"https://openalex.org/keywords/phospholipase-a2-receptor","display_name":"phospholipase A2 receptor","score":0.8339999914169312},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9110000133514404},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.9010000228881836},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.6359999775886536},{"id":"https://openalex.org/keywords/nephrotic-syndrome","display_name":"nephrotic syndrome","score":0.9020000100135803},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.5979999899864197},{"id":"https://openalex.org/keywords/glomerular-basement-membrane","display_name":"glomerular basement membrane","score":0.800000011920929},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.5509999990463257},{"id":"https://openalex.org/keywords/end-stage-kidney-disease-prevention","display_name":"end-stage kidney disease prevention","score":0.7110000252723694},{"id":"https://openalex.org/keywords/anti-b-cell-therapy","display_name":"anti-B-cell therapy","score":0.44999998807907104},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.822846531867981},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7235195636749268},{"id":"https://openalex.org/C2775946357","wikidata":"https://www.wikidata.org/wiki/Q1713037","display_name":"Membranous nephropathy","level":4,"score":0.6571683287620544},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5843943953514099},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5242571830749512},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5002810955047607},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.49631959199905396},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.4824829399585724},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.47398391366004944},{"id":"https://openalex.org/C2776115139","wikidata":"https://www.wikidata.org/wiki/Q1753456","display_name":"Glomerular basement membrane","level":4,"score":0.4570349454879761},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.4469001293182373},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.34318071603775024},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3358195126056671}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003167","descriptor_name":"Complement Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015433","descriptor_name":"Glomerulonephritis, Membranous","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015433","descriptor_name":"Glomerulonephritis, Membranous","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D015433","descriptor_name":"Glomerulonephritis, Membranous","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D054507","descriptor_name":"Receptors, Phospholipase A2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1681/asn.2011060610","doi":"https://doi.org/10.1681/asn.2011060610","is_oa":true,"landing_page_url":"https://doi.org/10.1681/asn.2011060610","pdf_url":"https://jasn.asnjournals.org/content/jnephrol/22/8/1400.full.pdf","source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},{"id":"pmid:21784892","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21784892","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology : JASN","raw_type":"Editorial"},{"id":"pmh:oai:zenodo.org:182922","doi":null,"is_oa":true,"landing_page_url":"https://www.openaccessrepository.it/record/182922","pdf_url":null,"source":{"id":"https://openalex.org/S4306402478","display_name":"INFM-OAR (INFN Catania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210116497","host_organization_name":"Istituto Nazionale di Fisica Nucleare, Sezione di Catania","host_organization_lineage":["https://openalex.org/I4210116497"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"doi:10.5281/zenodo.182922","doi":"https://doi.org/10.5281/zenodo.182922","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.182922","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Image"}],"best_oa_location":{"id":"doi:10.1681/asn.2011060610","doi":"https://doi.org/10.1681/asn.2011060610","is_oa":true,"landing_page_url":"https://doi.org/10.1681/asn.2011060610","pdf_url":"https://jasn.asnjournals.org/content/jnephrol/22/8/1400.full.pdf","source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2123676752.pdf","grobid_xml":"https://content.openalex.org/works/W2123676752.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1986167294","https://openalex.org/W2002032734","https://openalex.org/W2006128988","https://openalex.org/W2008615274","https://openalex.org/W2018459774","https://openalex.org/W2059147261","https://openalex.org/W2059481007","https://openalex.org/W2063340779","https://openalex.org/W2105893193","https://openalex.org/W2107002794","https://openalex.org/W2111650261","https://openalex.org/W2111892488","https://openalex.org/W2131815197","https://openalex.org/W2133344401","https://openalex.org/W2135619376","https://openalex.org/W2140565611","https://openalex.org/W2141219630","https://openalex.org/W2166822765","https://openalex.org/W2167795729","https://openalex.org/W2168768140","https://openalex.org/W4239292067"],"related_works":["https://openalex.org/W2184616726","https://openalex.org/W3032237473","https://openalex.org/W2727358944","https://openalex.org/W4362480391","https://openalex.org/W7130514553","https://openalex.org/W2140822346","https://openalex.org/W3124878700","https://openalex.org/W2053095951","https://openalex.org/W2107002794","https://openalex.org/W3043508064"],"abstract_inverted_index":{"Experimental":[0],"and":[1,39,44,103,112,186,276,284,303,314,337,364,506,529,550,924,967,981,990],"human":[2,445],"data":[3],"converge":[4],"to":[5,72,106,149,163,263,278,349,375,377,404,509,531,595,606,624,626,665,756,761,779,886,917,963],"indicate":[6],"that":[7,47,57,152,392,443,706,724,850,865,902],"deposition":[8],"along":[9],"the":[10,35,40,60,68,76,80,92,126,145,150,174,184,192,209,292,326,343,430,441,482,504,520,558,569,582,585,588,607,649,667,676,702,710,725,734,749,762,839,843,854,883,893,896,909,918,928,952],"glomerular":[11,36,698],"basement":[12],"membrane":[13],"of":[14,25,34,62,75,82,157,194,254,286,291,301,328,342,346,408,470,492,503,514,546,560,564,571,580,584,592,610,632,662,669,681,690,696,709,719,727,736,772,789,856,895,912,946,958,977],"immunoglobulins":[15],"produced":[16],"by":[17,183,230,701,764,858],"autoreactive":[18],"B":[19,179,227,394],"cells":[20,221],"may":[21,622,835,961,983],"initiate":[22],"a":[23,170,236,251,279,307,405,444,451,578,629,637,694,720,781,868,903],"sequence":[24,81],"events":[26,84],"resulting":[27],"in":[28,79,89,131,189,250,282,289,309,330,333,368,399,411,422,433,467,487,489,497,524,534,544,557,574,587,656,715,798,823,838,877,914,927,951,954,971,986],"complement":[29],"activation,1":[30],"impaired":[31],"sieving":[32],"function":[33],"capillary":[37],"wall":[38],"pore-forming":[41],"slit":[42],"diaphragm,2":[43],"eventual":[45],"proteinuria":[46,283,332,367,398,572,641,683,738,783,855,925,982],"characterizes":[48],"idiopathic":[49],"membranous":[50],"nephropathy":[51],"(IMN).3":[52],"Thus,":[53],"treatment":[54,193],"with":[55,114,159,205,258,306,335,354,401,435,538,577,614,671,717,774,800,814,935,956,973],"agents":[56,120],"selectively":[58],"inhibit":[59],"production":[61],"nephritogenic":[63,454],"antibodies":[64,458,803,834],"would":[65,652],"likely":[66],"be":[67,654,754,777,836,848,984],"most":[69],"effective":[70],"intervention":[71],"prevent":[73],"one":[74,299,575,621,770],"earliest":[77],"steps":[78],"pathogenic":[83,947],"underlying":[85],"progressive":[86],"renal":[87,415,729],"dysfunction":[88],"IMN.":[90,242,539],"Until":[91],"early":[93],"nineties,":[94],"however,":[95,768,901],"no":[96],"specific":[97,238,350,969],"anti-B":[98],"cell":[99,228,395],"therapies":[100],"were":[101,542],"available":[102],"therapeutic":[104,239],"approaches":[105],"IMN":[107,160,256,336,369,402,488,604,775,857,915],"mostly":[108],"relied":[109],"on":[110,178,215,640,648,731,871,906],"steroids":[111],"cytotoxics":[113],"or":[115,196,222,381,384,831],"without":[116,642],"calcineurin":[117,382],"inhibitors.":[118],"Such":[119],"have":[121,323,417,464,780,794],"significant":[122,280],"nonspecific":[123,355],"toxicity.":[124],"On":[125,675,842],"other":[127,223,321,677,828,844,936],"hand,":[128,678,845],"kidney":[129,165],"survival":[130],"patients":[132,158,204,257,334,370,400,537,547,613,658,773,799,972],"who":[133,371,385],"do":[134],"not":[135,140,213,811],"undergo":[136],"spontaneous":[137],"remission4":[138],"has":[139,478,795,867],"been":[141,418,465,479,796],"substantially":[142],"improved":[143],"over":[144,298],"last":[146],"30":[147],"yr,":[148],"extent":[151],"as":[153,155,235,359,429,450,481,693,873,940],"many":[154],"40%":[156],"still":[161],"progress":[162],"end-stage":[164],"disease":[166,505,965],"despite":[167,618,785],"treatment.5":[168],"Rituximab,":[169],"monoclonal":[171],"antibody":[172,633,884,922],"against":[173,459],"CD20":[175,210],"antigen":[176,211,432,447,485],"present":[177],"cells,":[180,218],"was":[181,247,273,296,304,427,874],"approved":[182],"Food":[185],"Drug":[187],"Administration":[188],"1997":[190],"for":[191,203,241,440,453,644,659],"relapsing":[195],"refractory":[197],"non-Hodgkin's":[198],"lymphoma":[199],"and,":[200,573],"more":[201],"recently,":[202,421,457],"rheumatoid":[206],"arthritis.6":[207],"Since":[208,317],"is":[212,714,810,862,899],"expressed":[214],"hematopoietic":[216],"stem":[217],"normal":[219,224],"plasma":[220],"tissues,":[225],"selective":[226,393],"depletion":[229,396],"rituximab":[231,246,329,362,532,555,740,851,866,913],"therapy":[232,533,556,605],"soon":[233],"surfaced":[234],"potential,":[237],"option":[240],"With":[243],"this":[244,318,412,512],"background,":[245],"initially":[248],"tested":[249],"small":[252],"cohort":[253],"eight":[255],"severe":[259],"nephrotic":[260,287,338],"syndrome":[261,288],"unresponsive":[262],"prolonged":[264,688],"angiotensin":[265,751],"converting":[266],"enzyme":[267],"(ACE)":[268],"inhibitor":[269],"therapy.7":[270],"Rituximab":[271],"infusion":[272],"well":[274],"tolerated":[275],"led":[277],"reduction":[281,308,563],"amelioration":[285],"all":[290],"cases.":[293],"The":[294],"effect":[295,639,905,911],"sustained":[297,630],"year":[300],"follow-up":[302],"associated":[305,805,813],"body":[310],"weight,":[311],"diastolic":[312],"BP,":[313],"serum":[315,462,525],"cholesterol.8":[316],"initial":[319,703],"experience,":[320],"groups":[322],"consistently":[324],"reported":[325,797],"efficacy":[327],"reducing":[331],"syndrome.9,10":[339],"In":[340,511,612,742,933],"confirmation":[341],"superior":[344],"effectiveness":[345],"interventions":[347,664],"targeted":[348],"pathogenetic":[351,406],"mechanisms":[352],"compared":[353],"immunosuppression,":[356],"when":[357],"used":[358],"second-line":[360],"treatment,":[361],"safely":[363],"persistently":[365,786],"reduced":[366],"had":[372,386],"previously":[373],"failed":[374],"respond":[376],"steroids,":[378],"alkylating":[379],"agents,":[380],"inhibitors,":[383],"relapsed":[387],"after":[388,554,687,739],"transient":[389],"remission.11,12":[390],"Finding":[391],"lowered":[397],"points":[403],"role":[407],"antibody-producing":[409],"lymphocytes":[410],"disease.":[413,593,611,674],"While":[414],"antigens":[416],"elusive":[419],"until":[420],"2002,":[423],"neutral":[424],"endopeptidase":[425],"(NEP)":[426],"identified":[428],"target":[431,452,887],"newborns":[434],"NEP-deficient":[436],"mothers,":[437],"providing":[438],"evidence":[439],"notion":[442],"podocyte":[446,484,907],"could":[448],"serve":[449],"antibodies.13":[455],"More":[456],"cationic":[460],"bovine":[461],"albumin":[463],"implicated":[466],"pediatric":[468],"cases":[469],"IMN.14":[471],"Finally,":[472],"M-type":[473],"phospholipase":[474],"A2":[475],"receptor":[476],"(PLA2R)":[477],"shown":[480,876],"first":[483],"involved":[486,837],"adults.15":[490],"Detection":[491],"these":[493,596,743,824],"autoantibodies":[494,541,600,827,950,980],"might":[495,601,776],"help":[496,602,962],"differentiating":[498],"primary":[499],"from":[500],"secondary":[501],"forms":[502],"monitoring":[507,598],"responses":[508],"treatment.":[510],"issue":[513],"JASN,":[515],"Beck":[516,765],"et":[517,766],"al.":[518],"evaluated":[519],"relationship":[521],"between":[522,921],"changes":[523],"anti-PLA2R":[526,565,599,790,830,979],"autoantibody":[527,566,586,616,650],"levels":[528,567,788],"response":[530,809],"35":[535],"adult":[536],"Circulating":[540],"detected":[543],"80%":[545],"at":[548],"baseline,":[549],"their":[551],"titers":[552],"decreased":[553],"majority":[559],"them.16":[561],"Importantly,":[562],"anticipated":[568],"decline":[570],"patient":[576,988],"relapse":[579],"proteinuria,":[581,620],"reemergence":[583],"circulation":[589],"preceded":[590],"recurrence":[591],"According":[594,760],"findings,":[597],"titrating":[603],"activity":[608,966],"level":[609],"declining":[615],"titer":[617,634,651,816,923],"stable":[619],"choose":[623],"wait":[625],"see":[627],"whether":[628],"normalization":[631],"simply":[635],"precedes":[636],"beneficial":[638,910],"need":[643],"further":[645],"intervention.":[646],"Information":[647],"also":[653,820,852,863],"valuable":[655],"selecting":[657],"clinical":[660,808,825],"trials":[661],"immunosuppressive":[663],"avoid":[666],"inclusion":[668],"subjects":[670],"less":[672],"active":[673],"some":[679],"degree":[680,735],"residual":[682,737],"can":[684,847],"persist":[685],"even":[686],"remission":[689,784],"autoimmune":[691,840,937],"response,":[692],"result":[695],"chronic":[697,728],"damage":[699],"induced":[700],"immunological":[704],"insult":[705],"progressed":[707],"independently":[708],"immune":[711],"process.":[712],"This":[713,818],"line":[716],"results":[718],"previous":[721],"report":[722],"showing":[723],"severity":[726],"lesions":[730],"biopsy":[732],"predicts":[733],"therapy.17":[741],"cases,":[744],"nonimmune":[745],"nephroprotective":[746],"strategies":[747],"targeting":[748],"renin":[750],"system":[752],"should":[753],"implemented":[755],"maximally":[757],"reduce":[758],"proteinuria.":[759],"findings":[763,793],"al.,":[767],"approximately":[769],"third":[771],"expected":[778],"partial":[782],"high":[787],"autoantibodies.":[791],"Similar":[792],"antineutrophil":[801,832],"cytoplasmic":[802,833],"(ANCA)":[804],"vasculitis,":[806],"where":[807,882,944],"always":[812],"ANCA":[815],"decline.18":[817],"finding":[819],"suggests":[821],"that,":[822],"conditions,":[826],"than":[829],"response.":[841],"it":[846],"speculated":[849],"reduces":[853],"immune-independent":[859],"mechanisms.":[860],"It":[861,898],"possible":[864],"direct":[869,904],"action":[870],"podocytes,":[872],"recently":[875],"focal":[878],"segmental":[879],"glomerulosclerosis":[880],"(FSGS),":[881],"appears":[885],"sphingomyelin":[888],"phosphodiesterase":[889],"acid-like":[890],"3b,":[891],"preventing":[892],"remodeling":[894],"cytoskeleton.19":[897],"unlikely,":[900],"explains":[908],"due":[916],"strong":[919],"correlation":[920],"documented":[926],"paper":[929],"under":[930],"consideration":[931],"here.":[932],"analogy":[934],"diseases":[938],"such":[939],"thrombotic":[941],"thrombocytopenic":[942],"purpura,":[943],"dosing":[945],"anti-ADAMTS":[948],"13":[949],"circulation,":[953],"combination":[955],"markers":[957],"microangiopathic":[959],"hemolysis,":[960],"monitor":[964],"guide":[968],"intervention20":[970],"IMN,":[974],"combined":[975],"assessment":[976],"circulating":[978],"instrumental":[985],"optimizing":[987],"care":[989],"hopefully":[991],"improving":[992],"long":[993],"term":[994],"outcomes.":[995],"DISCLOSURES":[996],"None.":[997]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}